Dr. Saw is a pioneer and leader in research and management of spontaneous coronary artery dissection (SCAD) (http://scad.ubc.ca), and is the principal investigator of the Canadian Institutes of Health Research (CIHR) funded multi-center prospective Canadian SCAD Study. Her other research interests include LAA closure, non-atherosclerotic coronary artery disease (including coronary fibromuscular dysplasia), antiplatelet therapy, percutaneous coronary intervention, carotid artery stenting, peripheral arterial disease and intervention. She is also the principal investigator of PRYME, NACAD, SAFER-SCAD, Canadian WATCHMAN Registry, TAP-CABG, and ELAPSE studies. She has authored over 100 peer-reviewed publications, including scientific research studies, review articles and book chapters. She is also the editor of three textbooks on carotid artery stenting and LAA closure.